Primary Site >> Biliary tract Cancer

Gene >> TXN

Journal: J Vet Sci. 2006 Sep;7(3):211-6.
Title: Altered expression of thioredoxin reductase-1 in dysplastic bile ducts and cholangiocarcinoma in a hamster model.
Author: Yoon, Byung Il|Kim, Dae Yong|Jang, Ja June|Han, Jeong Hee
PMID: 16871013
Journal: J Cell Biochem. 2009 Dec 15;108(6):1376-88.
Title: Proteomic analysis of differentially expressed proteins in human cholangiocarcinoma cells treated with Clonorchis sinensis excretory-secretory products.
Author: Pak, Jhang Ho|Moon, Ju Hyun|Hwang, Seung-Jun|Cho, Shin-Hyeong|Seo, Sang-Beom|Kim, Tong-Soo
PMID: 19798681
Journal: Cancer Sci. 2010 Jan;101(1):281-8.
Title: Expression of thioredoxin during progression of hamster and human cholangiocarcinoma.
Author: Yoon, Byung-Il|Kim, Yeong-Hun|Yi, Jung-Yeon|Kang, Min-Soo|Jang, Ja-June|Joo, Kyoung-Hwan|Kim, Yongbaek|McHugh Law, J|Kim, Dae-Yong
PMID: 19799607
Journal: Dig Dis Sci. 2012 May;57(5):1163-70.
Title: The value of thioredoxin family proteins and proliferation markers in dysplastic and malignant gallbladders in patients with primary sclerosing cholangitis.
Author: Said, Karouk|Glaumann, Hans|Bjornstedt, Mikael|Bergquist, Annika
PMID: 22370917
Journal: HPB (Oxford). 2012 Sep;14(9):573-82.
Title: Nuclear expression of thioredoxin-1 in the invasion front is associated with outcome in patients with gallbladder carcinoma.
Author: Nagano, Motoaki|Hatakeyama, Kinta|Kai, Masahiro|Nakamura, Hajime|Yodoi, Junji|Asada, Yujiro|Chijiiwa, Kazuo
PMID: 22882193
Journal: Tumour Biol. 2016 Aug;37(8):11495-507.
Title: Nrf2 inhibition sensitizes cholangiocarcinoma cells to cytotoxic and antiproliferative activities of chemotherapeutic agents.
Author: Samatiwat, Papavee|Prawan, Auemduan|Senggunprai, Laddawan|Kukongviriyapan, Upa|Kukongviriyapan, Veerapol
PMID: 27015836